Figure 5.

The expression of MMP-9 and TGF-beta1 in allografts and controls. A Expression of MMP-9 in the tubulointerstium of allografts and controls (100 ×). . The immunostaining of MMP-9 in tubulointerstitium of allografts (0.325 ± 0.093) significantly increased compared to either F344 controls (0.174 ± 0.052) and LEW controls (0.121 ± 0.047). B Expression of MMP-9 in the arteriolar wall of allografts and controls (100 ×). The immunostaining of MMP-9 in arteriolar wall of allografts significantly increased compared to F344 control. C Expression of TGF-beta1 in the tubulointerstium of allografts and controls (100 ×).The immunostaining of TGF-beta1 in tubulointerstitium of allografts significantly increased compared to either F344 controls or LEW controls. D Expression of TGF-beta1 in the arteriolar wall of allografts and controls (100 ×). The immunostaining of TGF-beta1 in arteriolar wall of allografts significantly increased compared to either F344 controls or LEW controls.